Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect
Abstract
The cucurbit[n]uril (CB[n]) family of
Maintenance work is planned from 09:00 BST to 12:00 BST on Saturday 28th September 2024.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
Institute of Cancer Sciences, University of Glasgow, Cancer Research UK Beatson Laboratories, Garscube Estate, Glasgow, UK
E-mail:
j.a.plumb@beatson.gla.ac.uk
b Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Arbuthnott Building, 161 Cathedral Street, Glasgow, UK
c Institute for Materials Research (IMR), Tohoku University, 2-1-1, Katahira, Sendai, Aoba-Ku, Japan
d
Faculty of Pharmacy, The University of Sydney, NSW, Australia
E-mail:
nial.wheate@sydney.edu.au
Fax: +61 2 9351 4391
The cucurbit[n]uril (CB[n]) family of
Fetching data from CrossRef.
This may take some time to load.
Loading related content